KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Prepaid Assets (2016 - 2025)

Vertex Pharmaceuticals has reported Prepaid Assets over the past 17 years, most recently at $853.3 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $853.3 million for Q4 2025, up 28.18% from a year ago — trailing twelve months through Dec 2025 was $853.3 million (up 28.18% YoY), and the annual figure for FY2025 was $853.3 million, up 28.18%.
  • Prepaid Assets for Q4 2025 was $853.3 million at Vertex Pharmaceuticals, up from $709.4 million in the prior quarter.
  • Over the last five years, Prepaid Assets for VRTX hit a ceiling of $853.3 million in Q4 2025 and a floor of $74.4 million in Q4 2022.
  • Median Prepaid Assets over the past 5 years was $525.6 million (2023), compared with a mean of $515.6 million.
  • Biggest five-year swings in Prepaid Assets: crashed 86.37% in 2022 and later soared 689.68% in 2024.
  • Vertex Pharmaceuticals' Prepaid Assets stood at $545.8 million in 2021, then crashed by 86.37% to $74.4 million in 2022, then grew by 13.31% to $84.3 million in 2023, then soared by 689.68% to $665.7 million in 2024, then grew by 28.18% to $853.3 million in 2025.
  • The last three reported values for Prepaid Assets were $853.3 million (Q4 2025), $709.4 million (Q3 2025), and $652.3 million (Q2 2025) per Business Quant data.